Evidence map›Paper›PMID 31117229›Full record

ReviewPathogens (Basel, Switzerland)2019

A Contemporary View of Respiratory Syncytial Virus (RSV) Biology and Strain-Specific Differences.

Mansi C Pandya, Sean M Callahan, Kyryll G Savchenko, Christopher C Stobart

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. The usual suspects: Respiratory syncytial virus and rhinovirus drive asthma development and exacerbation.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2025
    Review
  15. Article
  16. RSV: an overview of infection in adults.Pneumonia (Nathan Qld.) · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mansi C PandyaDepartment of Biological Sciences, Butler University, Indianapolis, IN 46208, USA. mpandya@butler.edu.
Sean M CallahanDepartment of Biological Sciences, Butler University, Indianapolis, IN 46208, USA. smcallah@butler.edu.
Kyryll G SavchenkoDepartment of Biological Sciences, Butler University, Indianapolis, IN 46208, USA. ksavchen@butler.edu.
Christopher C StobartDepartment of Biological Sciences, Butler University, Indianapolis, IN 46208, USA. cstobart@butler.edu.ORCID 0000-0003-1729-9769
Butler University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is a human respiratory pathogen which remains a leading viral cause of hospitalizations and mortality among infants in their first year of life. Here, we review the biology of RSV, the primary laboratory isolates or strains which have been used to best characterize the virus since its discovery in 1956, and discuss the implications for genetic and functional variations between the established laboratory strains and the recently identified clinical isolates.

Indexed as

respiratory syncytial virusRSVstrain-specific differencesviral evolution

Identifiers

PMID31117229
PMCPMC6631838
OpenAlexW2945649639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.